Search Results - "Harima, Tomoya"

A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report by Ikeda, Shinichiro, Hu, Qingjiang, Natsugoe, Keita, Harima, Tomoya, Tanaka, Yasushi, Kinoshita, Izumi, Nonaka, Kentaro, Nambara, Sho, Nakanishi, Ryota, Nakanoko, Tomonori, Ota, Mitsuhiko, Kimura, Yasue, Oki, Eiji, Oda, Yoshinao, Yoshizumi, Tomoharu

“…Primary adenocarcinoma of the duodenum is a rare neoplasm that is often microsatellite instability-high (MSI-H). Pembrolizumab, a monoclonal antibody, has been…”
Get full text

RAS mutant transverse colon cancer with multiple liver metastases achieving long-term disease-free survival with postoperative maintenance therapy with aflibercept + FOLFIRI and four repeated radical resections: a case report by Tanaka, Yasushi, Nakanishi, Ryota, Sato, Shota, Otake, Akihiko, Ryujin, Keiichiro, Ikeda, Shinichiro, Ebata, Yuho, Harima, Tomoya, Natsugoe, Keita, Yoshiyama, Takayuki, Shin, Yuki, Kawazoe, Tetsuro, Kudo, Kensuke, Zaitsu, Yoko, Hisamatsu, Yuichi, Ando, Koji, Nakashima, Yuichiro, Itoh, Shinji, Oki, Eiji, Oda, Yoshinao, Yoshizumi, Tomoharu

“…Background Management of patients with colorectal liver metastases (CRLMs) requires a multidisciplinary approach. For patients with progression of RAS mutant…”
Get full text